AJP - Regulatory, Integrative and Comparative Physiology, Vol 265, Issue 4 766-R771, Copyright © 1993 by American Physiological Society

ARTICLES

In vivo evidence for adrenal catecholamine release mediated by nonnicotinic mechanism: local medullary effect of VIP

N. Yamaguchi
Groupe de Recherche sur le Systeme Nerveux Autonome, Faculte de Pharmacie, Universite de Montreal, Quebec, Canada.

The aim of the present study was 1) to develop a model in anesthetized dogs in which local infusion of a given substance could be made to the adrenal gland without any systemic effects and 2) to show in this model the potential existence of a nonnicotinic mechanism involved in adrenal catecholamine secretion. Plasma catecholamine concentrations were determined by an high-performance liquid chromatography method. The local infusion into the left adrenolumbar artery (0.5 ml/min for 1 min) of either dimethylphenylpiperazinium (0.3-3.0 micrograms/ml) or vasoactive intestinal peptide (0.1-10.0 micrograms/ml) resulted in dose-dependent increases in both epinephrine and norepinephrine secretions. Neither aortic pressure nor plasma catecholamine levels altered during the drug infusion. The net increases in adrenal catecholamine secretion obtained with dimethylphenylpiperazinium were abolished by the nicotinic blockade with pentolinium (2 mg/ml, 0.5 ml/min for 2 min). However, the net catecholamine responses to vasoactive intestinal peptide remained unaffected in the presence of the same dose of pentolinium. The results suggest that there exists a nonnicotinic mechanism that may be implicated in the local regulation of medullary catecholamine secretion in the dog adrenal gland. This model may be a useful tool for studying local physiological role(s) of various neurotransmitters and neuromodulators in the adrenal secretory function in vivo.

This article has been cited by other articles:

				S. Lamouche and N. Yamaguchi PACAP release from the canine adrenal gland in vivo: its functional role in severe hypotension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R588 - R597. [Abstract] [Full Text] [PDF]

				S. Lamouche and N. Yamaguchi Role of PAC1 receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R510 - R518. [Abstract] [Full Text] [PDF]

				T. Nagayama, K. Masada, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Role of K+ channels in adrenal catecholamine secretion in anesthetized dogs Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R1125 - R1130. [Abstract] [Full Text] [PDF]

				G. Geng, R. Gaspo, F. Trabelsi, and N. Yamaguchi Role of L-type Ca2+ channel in PACAP-induced adrenal catecholamine release in vivo Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1339 - R1345. [Abstract] [Full Text] [PDF]